Tibolone vs combined HT
Vasomotor symptoms (tibolone 2.5 mg/d) · postmenopausal women with vasomotor symptoms
Tibolone probably leads to higher vasomotor symptoms (tibolone 2.5 mg/d) compared with combined HT (moderate certainty).
1 finding from 1 review
- Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes onlyOR 1.57 [1.18, 2.1]4 studies · 646 participantsModerate